One such example is [111In]In-EGF-SPECT-imaging, using a radiolabeled peptide conjugated to the transferrin receptor (TfR) targeting mAb OX26, which has been shown to detect brain tumours without EGF transport 136. The gene discussed is TFRC; the disease is brain neoplasm.